Ascendiant Capital Maintains Buy on IGC Pharma, Raises Price Target to $5.5

Ascendiant Capital analyst Edward Woo maintains IGC Pharma (AMEX:IGC) with a Buy and raises the price target from $5.25 to $5.5.